Bridging the future of cardiac stimulation: physiologic or leadless pacing?

cardiac stimulation conduction system pacing heart failure leadless pacing

Journal

Reviews in cardiovascular medicine
ISSN: 1530-6550
Titre abrégé: Rev Cardiovasc Med
Pays: Singapore
ID NLM: 100960007

Informations de publication

Date de publication:
17 Mar 2022
Historique:
received: 30 11 2021
revised: 11 01 2022
accepted: 26 01 2022
entrez: 29 3 2022
pubmed: 30 3 2022
medline: 19 4 2022
Statut: ppublish

Résumé

Cardiac simulation has moved from early life-saving pacemakers meant only to prevent asystole to current devices capable of physiologic stimulation for the treatment of heart rhythm and heart failure, that are also intended for remote patient and disease-progression monitoring. The actual vision of contemporary pacing aims to correct the electrophysiologic roots of mechanical inefficiency regardless of underlying structural heart diseases. The awareness of the residual cardiac dyssynchrony related to customary cardiac pacing has changed the concept of what truly represents "physiologic pacing". On a different perspective, leadless stimulation to abolish CIED surgery and prevent lead-related complications is becoming a priority both for young device recipients and for frail, elderly patients. Careful clinical evaluation attempts to bridge decision-making to patient-tailored therapy.

Identifiants

pubmed: 35345274
pii: S1530-6550(22)00431-8
doi: 10.31083/j.rcm2303107
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

107

Informations de copyright

© 2022 The Author(s). Published by IMR Press.

Déclaration de conflit d'intérêts

Mauro Biffi: educational activity and Speaker’s bureau for Biotronik, Boston Scientific, Medtronic, and Zoll. The other authors declare no conflicts of interest.

Auteurs

Giuseppe Pio Piemontese (GP)

Department of Cardiology, Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, 40138 Bologna, Italy.

Sebastiano Toniolo (S)

Department of Cardiology, Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, 40138 Bologna, Italy.

Mauro Biffi (M)

Department of Cardiology, Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.

Claudio Capobianco (C)

Department of Cardiology, Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, 40138 Bologna, Italy.

Lorenzo Bartoli (L)

Department of Cardiology, Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, 40138 Bologna, Italy.

Sergio Sorrentino (S)

Department of Cardiology, Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, 40138 Bologna, Italy.

Alessandro Minguzzi (A)

Department of Cardiology, Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, 40138 Bologna, Italy.

Andrea Angeletti (A)

Department of Cardiology, Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, 40138 Bologna, Italy.

Giovanni Statuto (G)

Department of Cardiology, Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, 40138 Bologna, Italy.

Matteo Ziacchi (M)

Department of Cardiology, Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.

Cristian Martignani (C)

Department of Cardiology, Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.

Giulia Massaro (G)

Department of Cardiology, Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, 40138 Bologna, Italy.

Igor Diemberger (I)

Department of Cardiology, Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, 40138 Bologna, Italy.

Alberto Spadotto (A)

Department of Cardiology, Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, 40138 Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH